source Post navigation Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada – GlobeNewswire Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada – StockTitan